SearcharxivSearch

arXiv subjects

Hamid Abdollahi

Publications and source records attributed to Hamid Abdollahi.

11 recordsLinked to original sources

Renal Blood Flow Quantification During Standard Myocardial Perfusion Imaging with Rubidium-82 Positron Emission Tomography

Background: Renal blood flow (RBF) is an important marker of kidney health, but noninvasive assessment is not routinely used in clinical imaging. We evaluated the feasibility and physiologic validity of quantifying renal transport of Rubidium-82 (K1) during standard myocardial perfusion imaging (MPI) PET. Methods: We studied 126 patients (age 60 +/- 12 years; 48% male; 51% Black) undergoing clinically indicated rest and stress Rb-82 MPI, in whom at least one kidney was partially visualized within the axial field of view. Volumes of interest were drawn over the visible renal cortex. K1 was estimated using a one-tissue compartment model with arterial input functions (AIF) derived from either the left ventricle (LV) or abdominal aorta. Results: LV-derived AIF produced physiologic and internally consistent flow estimates, whereas aorta-derived AIF systematically overestimated K1 and flow. LV-based measurements were therefore used for all analyses. K1 demonstrated nonlinear flow dependence consistent with the Renkin-Crone extraction model, plateauing at higher perfusion states. Renal K1 and flow declined progressively with worsening kidney function, from 1.24 +/- 0.35 ml/min/g (eGFR >= 60) to 0.53 +/- 0.22 ml/min/g (eGFR < 15; P < 0.0001). Only patients with preserved eGFR showed significant hyperemic augmentation. ROC analysis demonstrated excellent discrimination for reduced kidney function (AUC > 0.90). Conclusion: Opportunistic renal K1 quantification during routine Rb-82 PET is feasible, physiologically consistent, and strongly associated with kidney function.

physics.med-ph

Beyond the Tumor: Recurrence-Prone Radiomics for Prognostication in Negative PSMA PET/CT scans of Prostate Cancer

In patients with biochemical recurrence of prostate cancer and negative PSMA PET/CT, radiomics features extracted from recurrence-prone organs can predict clinical progression and progression-free survival. In a cohort of 132 patients, combining PET/CT radiomics with clinical variables significantly improved prognostic performance (C-index 0.74 vs. 0.65). Model performance was influenced by reader diagnostic certainty and remained robust on external validation. These findings suggest that radiomics from visually negative scans capture subclinical disease and provide added value for risk stratification.

physics.med-ph

Virtual Theranostic Trials: New Approach Methodologies (NAMs) and Precision Radiopharmaceutical Therapies

Radiopharmaceutical therapies are expanding rapidly, but clinical evidence generation is limited by operational constraints and biological heterogeneity in radiopharmaceutical delivery and radiation risk. Virtual theranostic trials can run as companion trials, linking quantitative imaging to patient-specific models to generate evidence for personalized injections and scheduling, accelerate development, and broaden access.

physics.med-ph

Predictive Dosimetry in PSMA-Targeted Radiopharmaceutical Therapies: A PBPK Modeling and Machine Learning Study

Predictive dosimetry is central to enabling personalized radiopharmaceutical therapy (RPT), particularly in prostate specific membrane antigen (PSMA) targeted theranostics. In this work, we develop a three layer computational framework that integrates physiologically based pharmacokinetic (PBPK) modeling with machine learning (ML) to predict both physical (AUC, absorbed dose) and biological (BED, EQD2) dosimetric endpoints in tumors and major organs. In the first layer, we generated 640 virtual patients using PBPK simulations of F-18, Ga-68, and Cu-64 labeled PSMA PET tracers paired with Lu-177 PSMA therapy, producing 15360 tumor and organ time activity curves (TACs) under realistic biological variability and PET-like noise. In the second layer, TACs were transformed into quantitative kinetic features and mapped to physical and biological dose metrics. In the third layer, ML models (Random Forest, Extra Trees, Ridge, Gradient Boosting, and XGBoost) were trained to predict RPT doses from PET derived features, with performance evaluated using mean absolute percentage error (MAPE) and R2. Cu-64 PSMA-617 based PET yielded the most robust predictions, achieving tumor dose MAPE as low as 8 percent and 10 to 20 percent for normal organs, while F-18 DCFPyL showed volume dependent performance and Ga-68 PSMA-11 exhibited higher variability. SHAP analysis revealed that peak uptake, clearance, and early kinetic features dominated predictive performance across organs and endpoints. This PBPK ML framework enables scalable, physiology informed predictive dosimetry and provides a foundation for trial design and patient specific treatment planning in PSMA targeted RPT. These results demonstrate that pre therapy PET can serve as a reliable surrogate for post therapy dosimetry, enabling scalable personalization of PSMA targeted RPT.

physics.med-ph

Quantitative and Computational Radiobiology for Precision Radiopharmaceutical Therapies

This article reviews the evolving field of radiobiology, emphasizing the need for advanced multiscale, mechanistic models to optimize radiopharmaceutical therapies (RPT). While the traditional linear-quadratic (LQ) model underpins external beam radiation therapy (EBRT), RPT's unique biological and spatial complexities demand new approaches. First-principles simulations of DNA damage, repair, and multicellular responses are crucial for understanding therapeutic efficacy and toxicity. The integration of these models into personalized, digital twin frameworks promises transformative clinical applications, but progress depends on deep mechanistic insights, experimental validation, and balancing model complexity with practicality for clinical use.

physics.med-ph

Probing Multimodal Fusion in the Brain: The Dominance of Audiovisual Streams in Naturalistic Encoding

Predicting brain activity in response to naturalistic, multimodal stimuli is a key challenge in computational neuroscience. While encoding models are becoming more powerful, their ability to generalize to truly novel contexts remains a critical, often untested, question. In this work, we developed brain encoding models using state-of-the-art visual (X-CLIP) and auditory (Whisper) feature extractors and rigorously evaluated them on both in-distribution (ID) and diverse out-of-distribution (OOD) data. Our results reveal a fundamental trade-off between model complexity and generalization: a higher-capacity attention-based model excelled on ID data, but a simpler linear model was more robust, outperforming a competitive baseline by 18\% on the OOD set. Intriguingly, we found that linguistic features did not improve predictive accuracy, suggesting that for familiar languages, neural encoding may be dominated by the continuous visual and auditory streams over redundant textual information. Spatially, our approach showed marked performance gains in the auditory cortex, underscoring the benefit of high-fidelity speech representations. Collectively, our findings demonstrate that rigorous OOD testing is essential for building robust neuro-AI models and provides nuanced insights into how model architecture, stimulus characteristics, and sensory hierarchies shape the neural encoding of our rich, multimodal world.

cs.CV

Non-Invasive Fuhrman Grading of Clear Cell Renal Cell Carcinoma Using Computed Tomography Radiomics Features and Machine Learning

Purpose: To identify optimal classification methods for computed tomography (CT) radiomics-based preoperative prediction of clear cells renal cell carcinoma (ccRCC) grade. Methods and material: Seventy one ccRCC patients were included in the study. Three image preprocessing techniques (Laplacian of Gaussian, wavelet filter, and discretization of the intensity values) were applied on tumor volumes. In total, 2530 radiomics features (tumor shape and size, intensity statistics, and texture) were extracted from each segmented tumor volume. Univariate analysis was performed to assess the association of each feature with the histological condition. In the case of multivariate analysis, the following was implemented: three feature selection including the least absolute shrinkage and selection operator (LASSO), students t-test and minimum Redundancy Maximum Relevance (mRMR) algorithms. These selected features were then used to construct three classification models (SVM, random forest, and logistic regression) to discriminate the high from low-grade ccRCC at nephrectomy. Lastly, multivariate model performance was evaluated on the bootstrapped validation cohort using the area under receiver operating characteristic curve (AUC). Results: Univariate analysis demonstrated that among different image sets, 128 bin discretized images have statistically significant different (q-value < 0.05) texture parameters with a mean of AUC 0.74 (q-value < 0.05). The three ML-based classifier shows proficient discrimination of the high from low-grade ccRCC. The AUC was 0.78 in logistic regression, 0.62 in random forest, and 0.83 in SVM model, respectively. Conclusion: Radiomics features can be a useful and promising non-invasive method for preoperative evaluation of ccRCC Fuhrman grades. Key words: RCC, Radiomics, Machine Learning, Computed Tomography

physics.med-ph

Cardiac SPECT Radiomics Features Repeatability and Reproducibility: A Multi Scanner Phantom Study

Background: The aim of this study was to assess the robustness of cardiac SPECT radiomics features against changes in imaging settings including acquisition and reconstruction settings. Methods: Four scanners were used to acquire SPECT scans of a cardiac phantom with 5mCi of 99mTc. The effects of different image acquisition and reconstruction settings including the Number of View, View Matrix Size, attenuation correction, image reconstruction algorithm, number of iterations, number of subsets, type of filter, full width at half maximum (FWHM) of Gaussian filter, Butterworth filter order, and Butterworth filter cut-off were studied. In total 5263 different images were reconstructed. Eighty-seven radiomic features including first, second, and high order textures were extracted from images. To assess reproducibility and repeatability the coefficient of variation (COV) was used for each image feature over the different imaging settings. Result: IDMN and IDN features from GLCM, RP from GLRLM, ZE from GLSZM, and DE from GLDM feature sets were the only features that were the most reproducible (COV < 5) against changes in all imaging settings. In addition, the IDMN feature from GLCM, LALGLE, SALGLE and LGLZE from GLSZM, and SDLGLE from GLDM feature sets were the features that were less reproducible (COV>20 ) against changes in all imaging settings. Matrix size has the greatest impact on feature variability as most of features are not repeatable and 82.76 of them had (COV>20 ). Conclusion: Repeatability and reproducibility of SPECT radiomics texture features in different imaging settings is feature-dependent, and different image acquisitions and reconstructions have different effects on radiomics texture features. Low COV radiomics features could be consider for further clinical studies. Keywords: SPECT, Radiomics, Cardiac, Repeatability, Reproducibility

physics.med-ph

Non-Invasive MGMT Status Prediction in GBM Cancer Using Magnetic Resonance Images (MRI) Radiomics Features: Univariate and Multivariate Machine Learning Radiogenomics Analysis

Background and aim: This study aimed to predict methylation status of the O-6 methyl guanine-DNA methyl transferase (MGMT) gene promoter status by using MRI radiomics features, as well as univariate and multivariate analysis. Material and Methods: Eighty-two patients who had a MGMT methylation status were include in this study. Tumor were manually segmented in the four regions of MR images, a) whole tumor, b) active/enhanced region, c) necrotic regions and d) edema regions (E). About seven thousand radiomics features were extracted for each patient. Feature selection and classifier were used to predict MGMT status through different machine learning algorithms. The area under the curve (AUC) of receiver operating characteristic (ROC) curve was used for model evaluations. Results: Regarding univariate analysis, the Inverse Variance feature from gray level co-occurrence matrix (GLCM) in Whole Tumor segment with 4.5 mm Sigma of Laplacian of Gaussian filter with AUC: 0.71 (p-value: 0.002) was found to be the best predictor. For multivariate analysis, the decision tree classifier with Select from Model feature selector and LOG filter in Edema region had the highest performance (AUC: 0.78), followed by Ada Boost classifier with Select from Model feature selector and LOG filter in Edema region (AUC: 0.74). Conclusion: This study showed that radiomics using machine learning algorithms is a feasible, noninvasive approach to predict MGMT methylation status in GBM cancer patients Keywords: Radiomics, Radiogenomics, GBM, MRI, MGMT

physics.med-ph

Next Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Approaches

Aim: In the present work, we aimed to evaluate a comprehensive radiomics framework that enabled prediction of EGFR and KRAS mutation status in NSCLC cancer patients based on PET and CT multi-modalities radiomic features and machine learning (ML) algorithms. Methods: Our study involved 211 NSCLC cancer patient with PET and CTD images. More than twenty thousand radiomic features from different image-feature sets were extracted Feature value was normalized to obtain Z-scores, followed by student t-test students for comparison, high correlated features were eliminated and the False discovery rate (FDR) correction were performed Six feature selection methods and twelve classifiers were used to predict gene status in patient and model evaluation was reported on independent validation sets (68 patients). Results: The best predictive power of conventional PET parameters was achieved by SUVpeak (AUC: 0.69, P-value = 0.0002) and MTV (AUC: 0.55, P-value = 0.0011) for EGFR and KRAS, respectively. Univariate analysis of radiomics features improved prediction power up to AUC: 75 (q-value: 0.003, Short Run Emphasis feature of GLRLM from LOG preprocessed image of PET with sigma value 1.5) and AUC: 0.71 (q-value 0.00005, The Large Dependence Low Gray Level Emphasis from GLDM in LOG preprocessed image of CTD sigma value 5) for EGFR and KRAS, respectively. Furthermore, the machine learning algorithm improved the perdition power up to AUC: 0.82 for EGFR (LOG preprocessed of PET image set with sigma 3 with VT feature selector and SGD classifier) and AUC: 0.83 for KRAS (CT image set with sigma 3.5 with SM feature selector and SGD classifier). Conclusion: We demonstrated that radiomic features extracted from different image-feature sets could be used for EGFR and KRAS mutation status prediction in NSCLC patients, and showed that they have more predictive power than conventional imaging parameters.

physics.med-ph

PET/CT Radiomic Sequencer for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients

The aim of this study was to develop radiomic models using PET/CT radiomic features with different machine learning approaches for finding best predictive epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene (KRAS) mutation status. Patients images including PET and CT [diagnostic (CTD) and low dose CT (CTA)] were pre-processed using wavelet (WAV), Laplacian of Gaussian (LOG) and 64 bin discretization (BIN) (alone or in combinations) and several features from images were extracted. The prediction performance of model was checked using the area under the receiver operator characteristic (ROC) curve (AUC). Results showed a wide range of radiomic model AUC performances up to 0.75 in prediction of EGFR and KRAS mutation status. Combination of K-Best and variance threshold feature selector with logistic regression (LREG) classifier in diagnostic CT scan led to the best performance in EGFR (CTD-BIN+B-KB+LREG, AUC: mean 0.75 sd 0.10) and KRAS (CTD-BIN-LOG-WAV+B-VT+LREG, AUC: mean 0.75 sd 0.07) respectively. Additionally, incorporating PET, kept AUC values at ~0.74. When considering conventional features only, highest predictive performance was achieved by PET SUVpeak (AUC: 0.69) for EGFR and by PET MTV (AUC: 0.55) for KRAS. In comparison with conventional PET parameters such as standard uptake value, radiomic models were found as more predictive. Our findings demonstrated that non-invasive and reliable radiomics analysis can be successfully used to predict EGFR and KRAS mutation status in NSCLC patients.

physics.med-ph